| Bioactivity | BMY-21502 (BMS-181168) is a pyrrolidinone derivative with memory- and cognition-enhancing activities. BMS-181168 attenuates hypoxia-induced deterioration in brain function, as delta/theta decreases, alpha activity increases and the centroid of the combined delta/theta waves is accelerated[1]. |
| CAS | 123259-91-6 |
| Formula | C15H19F3N4O |
| Molar Mass | 328.33 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Saletu B, et al. BMS-181168 for protection of the human brain against hypoxia: double-blind, placebo-controlled EEG mapping studies. Pharmacopsychiatry. 1994 Sep;27(5):189-97. |
BMY-21502
CAS: 123259-91-6 F: C15H19F3N4O W: 328.33
BMY-21502 (BMS-181168) is a pyrrolidinone derivative with memory- and cognition-enhancing activities. BMS-181168 attenua
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.